Suchergebnisse - "Powles, T"

PubPharm (507)

1

Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma : extended follow-up from the phase III randomised CheckMate 9ER trial

enthalten in: ESMO open | 2024

von Powles, T. | Burotto, M. | Escudier, B. | +17

2

ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Powles, T. | Bellmunt, J. | Comperat, E. | +11

3

EV-301 long-term outcomes : 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Rosenberg, J. | Powles, T. | Sonpavde, G. | +11

4

Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors : a phase II, open-label, multicenter, multicohort study

enthalten in: ESMO open | 2023

von Sherman, E. | Lee, J. | Debruyne, P. | +9

5

Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma : results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Balar, A. | Castellano, D. | Grivas, P. | +17

6

Testicular seminoma and non-seminoma : ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Oldenburg, J. | Berney, D. | Bokemeyer, C. | +12

7

Bladder cancer : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Powles, T. | Bellmunt, J. | Comperat, E. | +11

CommentIn: Ann Oncol. 2022 May;33(5):561. - PMID 35121006

8

ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Powles, T. | Albiges, L. | Bex, A. | +7

CommentIn: Ann Oncol. 2021 Dec;32(12):1466-1467. - PMID 34718116

9

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma

enthalten in: ESMO open | 2021

von Kanesvaran, R. | Porta, C. | Wong, A. | +21

10

Checkpoint inhibitors in metastatic papillary renal cell carcinoma

enthalten in: Cancer treatment reviews | 2021

von de Vries-Brilland, M. | McDermott, D. | Suárez, C. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[51]